Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z9QR
|
||||
Former ID |
DAP000703
|
||||
Drug Name |
Zalcitabine
|
||||
Synonyms |
DdC; DdCyd; Dideoxycytidine; HIVID; Zalcitibine; D 5782; DDC (DDC); DdC & Interferon alpha; DdC & sCD4; DdC (Antiviral); Hivid (TN); Hivid(TM); Interferon AD + ddC; KS-1130; SRI-7707; Beta-D-DDC; DS-4152 & ddC; DdC & GM-CSF; DdC & IFN-alpha; DdC & NP (from PHCA or HSA); PC-SOD & ddC; Ro 24-2027/000; Zalcitabine [USAN:INN:BAN]; Hivid, Dideoxycytidine, NSC 606170, Zalcitabine; Ro-24-2027/000; Zalcitabine (JAN/USP/INN); Beta-D-2',3'-Dideoxycytidine; Cytidine, 2',3'-dideoxy & Interferon alpha; Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine; Cytidine, 2',3'-dideoxy-& Colony-stimulating factor; Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor; Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine; 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine; 2',3'-DIDEOXYCYTIDINE; 2',3'-Dideoxycytidine & Interferon-alpha; 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein); 2,3-dideoxycytidine; 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anti-HIV Agents
|
||||
Company |
Hoffmann-La Roche pharmaceutical company
|
||||
Structure |
Download2D MOL |
||||
Formula |
C9H13N3O3
|
||||
InChI |
InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1
|
||||
InChIKey |
WREGKURFCTUGRC-POYBYMJQSA-N
|
||||
CAS Number |
CAS 7481-89-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9416, 595891, 596441, 596607, 596679, 601537, 602107, 878108, 3259589, 7847478, 7980904, 8167576, 11467065, 11468185, 11486840, 11504751, 11528334, 11532889, 14797711, 15171927, 17389522, 17404923, 22391526, 22431601, 24278377, 24862834, 25819962, 26719633, 26752752, 26752753, 29291163, 46386814, 46488030, 46507879, 47216920, 47216921, 47589142, 48185139, 48334652, 48416706, 48422195, 48422429, 48423540, 48424478, 49681781, 49693297, 49699414, 49734166, 50105404, 50105405
|
||||
SuperDrug ATC ID |
J05AF03
|
||||
SuperDrug CAS ID |
cas=007481892
|
||||
Target and Pathway | |||||
Target(s) | HIV reverse transcriptase | Target Info | Inhibitor | [535977] | |
References | |||||
Ref 468060 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4828). | ||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.